UTI - Healthcare Fund holds 46 instruments (94.15% equity), led by Sun Pharmaceutical Industries Limited (7.62%), Divi's Laboratories Limited (6.15%) and Dr. Reddy's Laboratories Limited (5.24%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of UTI - Healthcare Fund, managed by UTI Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 46 instruments with an equity allocation of 94.15%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
UTI - Healthcare Fund's top 10 holdings account for 43.48% of its portfolio, more diversified than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 91.48% of net assets, spread across 2 sectors in total. Since its 31 August 2026 disclosure, the fund added 1 new position and exited 0 positions, with Dr. Reddy's Laboratories Limited seeing the largest move (+1.62pp to 5.24%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Dr. Reddy's Laboratories Limited | 3.62% → 5.24% | ▲ +1.62 |
| Cohance Lifesciences Limited | 2.21% → 2.79% | ▲ +0.58 |
| Blue Jet Healthcare Limited | 0.99% → 1.41% | ▲ +0.42 |
| Alkem Laboratories Limited | 3.29% → 3.7% | ▲ +0.41 |
| Gland Pharma Limited | 3.7% → 4.06% | ▲ +0.36 |
| Alembic Pharmaceuticals Limited | 1.16% → 1.4% | ▲ +0.24 |
| Biocon Limited | 1.42% → 1.62% | ▲ +0.2 |
| Global Health Limited | 2.81% → 2.96% | ▲ +0.15 |
| Windlas Biotech Limited | 1.28% → 1.42% | ▲ +0.14 |
| Aarti Pharmalabs Limited | 0.88% → 1% | ▲ +0.12 |
| Stock | Weight | Change |
|---|---|---|
| Anthem Biosciences Limited | 2.62% → 1.8% | ▼ -0.82 |
| Emcure Pharmaceuticals Limited | 0.89% → 0.2% | ▼ -0.69 |
| Sun Pharmaceutical Industries Limited | 8.25% → 7.62% | ▼ -0.63 |
| Sai Life Sciences Limited | 1.79% → 1.26% | ▼ -0.53 |
| Fortis Healthcare Limited | 2.36% → 2.02% | ▼ -0.34 |
| Max Healthcare Institute Limited | 3.1% → 2.8% | ▼ -0.3 |
| Apollo Hospitals Enterprise Limited | 3.27% → 3.03% | ▼ -0.24 |
| Lupin Limited | 3.09% → 2.89% | ▼ -0.2 |
| Pfizer Limited | 1.11% → 0.93% | ▼ -0.18 |
| Viyash Scientific Limited | 1.54% → 1.39% | ▼ -0.15 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: UTI Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.